semaglutide lawsuit update Ozempic update: Here’s what’s going on ⬇️, As of October 18, 2025, lawsuits against Novo Nordisk, the maker of Ozempic (semaglutide), are still ongoing — alleging the drug caused serious side Lawsuit could challenge trust in

These fluctuations in immune function can be problematic because they can and do influence thyroid gland function

What does Semaglutide 3mg treat

Several factors associated with GLP-1 use can contribute to this shift: Rapid weight loss Reduced caloric intake Potential nutrient deficiencies, especially protein, iron, and zinc Hormonal and metabolic changes These changes do not damage the hair follicle itself, which is why the condition is often reversible once the body stabilizes

For instance, in a pilot phase-I clinical study by Dorr et al., three subjects were subcutaneously administered a starting dose of 0.01 mg/kg of MT-II, followed by daily injections of MT-II or placebo for two consecutive weeks

Both backed by decades of published research